Nakatsu, Japan

Tadao Nakamura

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadao Nakamura. Retrieved from https://idiyas.com/inventor/tadao-nakamura-qm4b3bmm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tadao Nakamura: Innovator in Polyazaheterocycle Compounds

Introduction

Tadao Nakamura is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on polyazaheterocycle compounds. His research has implications for calcium antagonistic and agonistic activities, which are crucial in various medical applications.

Latest Patents

Nakamura holds a patent for polyazaheterocycle compounds, specifically a compound of the formula: ##STR1## or a pharmaceutically acceptable salt thereof. Each symbol in the formula is defined in the specification. This invention showcases his expertise in developing compounds that exhibit important pharmacological activities.

Career Highlights

Tadao Nakamura is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Nakamura has collaborated with esteemed colleagues such as Tadashi Mishina and Minoru Obata. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Tadao Nakamura's contributions to the field of pharmaceuticals through his patent on polyazaheterocycle compounds highlight his role as an innovator. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…